» Articles » PMID: 32522907

Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study

Abstract

Aim: This study aimed to investigate the association between the serum high-sensitivity C-reactive protein (hs-CRP) levels and incident atrial fibrillation risk in the general Japanese population, who have lower hs-CRP levels than the Western population, and assess whether the association is modified by sex, overweight, hypertension, and smoking status.

Methods: We conducted a prospective study in 6517 Japanese men and women aged 40-79 years without atrial fibrillation at baseline and enrolled in the Circulatory Risk in Communities Study (2002-2008). The hs-CRP levels were measured using the latex particle-enhanced immunonephelometric assay. Atrial fibrillation was identified using standard 12-lead electrocardiograms and information on physician-diagnosed atrial fibrillation history from the follow-up surveys. We used a Cox proportional hazard regression stratified by community.

Results: During a median follow-up of 11 years, 127 new cases of atrial fibrillation (74 and 53 cases among men and women, respectively) were found. Compared to the lowest quintile of hs-CRP levels, the multivariable hazard ratios (95% confidence intervals) were 2.54 (1.17-5.50), 2.28 (1.06-4.93), 2.92 (1.37-6.23), and 2.77 (1.30-5.91) for the second, third, fourth, and fifth (highest) quintiles, respectively. There was no significant effect modification by sex, overweight, hypertension, and smoking status (P for interaction >0.05).

Conclusions: Elevated hs-CRP levels were significantly associated with increased risk of atrial fibrillation in the Japanese population. The association of hs-CRP levels with incident atrial fibrillation did not vary according to sex, overweight, hypertension status, or smoking status.

Citing Articles

A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.

Johnston B, Downes M, Hall A, Thomas Z, Welters I PLoS One. 2025; 20(1):e0318365.

PMID: 39879166 PMC: 11778662. DOI: 10.1371/journal.pone.0318365.


Association of Estimated Glomerular Filtration Rate (eGFR) and High-Sensitivity C-Reactive Protein (Hs-CRP) with the Risk of New-Onset Atrial Fibrillation in Patients with Diabetes.

Liu Y, Liu H, Sun D, Zheng Y, Tse G, Chen K J Inflamm Res. 2025; 18():91-103.

PMID: 39780989 PMC: 11708200. DOI: 10.2147/JIR.S493068.


Lipid-lowering drugs, circulating inflammatory factors, and atrial fibrillation: a mediation Mendelian randomization study.

Ou G, Zhang Y, Cai H, Yao K, Qiu Z, Chen Y Front Cardiovasc Med. 2024; 11:1446610.

PMID: 39563941 PMC: 11573524. DOI: 10.3389/fcvm.2024.1446610.


A linear positive association between high-sensitivity C-reactive protein and the prevalence of cardiovascular disease among individuals with diabetes.

Liu Y, He W, Ji Y, Wang Q, Li X BMC Cardiovasc Disord. 2024; 24(1):411.

PMID: 39118024 PMC: 11308650. DOI: 10.1186/s12872-024-04091-8.


Gene Polymorphism and Recurrent Atrial Fibrillation after Catheter Ablation: A Comprehensive Review.

Wang M, Xue C, Shi S, Yang L, Zhu Z, Li J Rev Cardiovasc Med. 2024; 24(4):119.

PMID: 39076272 PMC: 11273024. DOI: 10.31083/j.rcm2404119.


References
1.
Rahman F, Kwan G, Benjamin E . Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014; 11(11):639-54. DOI: 10.1038/nrcardio.2014.118. View

2.
Odutayo A, Wong C, Hsiao A, Hopewell S, Altman D, Emdin C . Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016; 354:i4482. DOI: 10.1136/bmj.i4482. View

3.
Schnabel R, Larson M, Yamamoto J, Sullivan L, Pencina M, Meigs J . Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010; 121(2):200-7. PMC: 3224826. DOI: 10.1161/CIRCULATIONAHA.109.882241. View

4.
Conen D, Ridker P, Everett B, Tedrow U, Rose L, Cook N . A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010; 31(14):1730-6. PMC: 2903714. DOI: 10.1093/eurheartj/ehq146. View

5.
Kwon C, Kang J, Lee H, Kim N, Sung J, Cheong E . C-reactive protein and risk of atrial fibrillation in East Asians. Europace. 2016; 19(10):1643-1649. DOI: 10.1093/europace/euw298. View